Clinical research studyAge and Gender Differences in Quality of Care and Outcomes for Patients with ST-segment Elevation Myocardial Infarction
Section snippets
Data Source and Study Population
Patients enrolled in the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) registry, a prospective, multicenter, national, observational registry and quality improvement initiative established by the American Heart Association, were chosen for this analysis.13, 14 For the purposes of the present analysis, patients were included if the initial electrocardiogram showed new ST-segment elevation or a new left bundle branch block or a diagnosis of ST-segment elevation myocardial infarction.
Baseline Characteristics and In-Hospital Treatment
Among the 31,544 patients with ST-segment elevation myocardial infarction, 3257 (10.3%) were categorized as young (aged ≤ 45 years). When compared with the older cohort, the younger cohort were more likely to be men, black, or Hispanic, and to smoke, but were less likely to have traditional risk factors (Table 1) and had higher body mass index, baseline heart rate, and systolic blood pressure, but were less likely to be taking medications before admission. A high percentage of both groups
Discussion
Our analysis of data from approximately 32,000 patients with ST-segment elevation myocardial infarction, from 369 sites, showed that the young patients presenting with ST-segment elevation myocardial infarction were more likely to be men, smokers, black, or Hispanic, whose quality of care and in-hospital outcomes were similar to or better than that of their older counterparts. In addition with the implementation of the GWTG program, the “all or none” composite performance measure has steadily
Study Limitations
Our data are from a prospective registry. However, this is still the largest series on young patients with ST-segment elevation myocardial infarction. Our data included only hospitalized patients with ST-segment elevation myocardial infarction and did not account for out-of-hospital deaths. In addition, we were able to assess only in-hospital outcomes. In our subgroup analysis, we did not have data on illicit drug use in the very young cohort. In addition, given the lack of angiographic data,
Conclusions
In this largest series to date, younger patients with ST-segment elevation myocardial infarction were more likely to be men, black or Hispanic, or smokers, whose quality of care and in-hospital outcomes were similar to or better than that of their older counterparts. There was significantly lower quality of care as assessed by performance measures and significantly worse outcomes in young women (vs young men) and the very young (≤35 vs 36-45 years), suggesting the need for increasing awareness
References (26)
- et al.
Acute myocardial infarction in the young—the University of Michigan experience
Am Heart J
(2002) - et al.
Thirty-year (1975 to 2005) trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction
The Am J Cardiol
(2011) - et al.
Myocardial infarction in young adults: risk factors and clinical features
J Emerg Med
(1996) - et al.
Acute coronary syndromes in young patients: presentation, treatment and outcome
Int J Cardiol
(2011) - et al.
Using “get with the guidelines” to improve cardiovascular secondary prevention
Jt Comm J Qual Saf
(2003) - et al.
Myocardial infarction before age 36: Risk factor and arteriographic analysis
Am J Cardiol
(1982) - et al.
Historic and angiographic features of young adults surviving myocardial infarction
Chest
(1979) - et al.
Coronary artery disease in young women: clinical and angiographic features and correlation with risk factors
Am J Cardiol
(1978) - et al.
Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (coronary artery surgery study registry)
J Am Coll Cardiol
(1995) - et al.
Comparison of thrombolytic therapy for acute myocardial infarction in patients aged < 35 and > 55 years
Am J Cardiol
(1993)
Myocardial infarction in young peopleExperience in U.S.S.R
Am Heart J
Acute myocardial infarction in women: contribution of treatment variables to adverse outcome
Am Heart J
Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction
J Am Coll Cardiol
Cited by (0)
Funding: The Get With The Guidelines-Coronary Artery Disease (GWTG-CAD) program was provided by the American Heart Association. The GWTG-CAD program was supported in part through the American Heart Association Pharmaceutical Roundtable and an unrestricted educational grant from Merck.
Conflicts of Interest: Sripal Bangalore: advisory board for Daichii Sankyo. Gregg C. Fonarow: consulting for Novartis Pfizer. Eric Peterson: research funding from BMS/Sanofi, Eli Lilly, Merck, and Ortho McNeil Pharmaceuticals. Anne S. Hellkamp: none. Adrian F. Hernandez: none. Warren Laskey: none. Frank Peacock: scientific advisory board for Abbott, Beckman-Coulter, Biosite, and The Medicines Co; research grants for Abbott, BAS, Biosite, Brahms, Nanosphere, EKR, and The Medicines Co; speakers bureau for Abbott, Biosite, and The Medicines Co; ownership interest in Vital Sensors. Christopher P. Cannon: research grants/support from Accumetrics, AstraZeneca, Glaxo Smith Kline, Merck, and Takeda; advisory board (but funds donated to charity) for Bristol-Myers Squibb/Sanofi, Novartis, and Alnylam; honorarium for development of independent educational symposia for Pfizer and AstraZeneca; clinical advisor for and equity in Automedics Medical Systems. Lee Schwamm: Chair, GWTG steering committee (unpaid). Deepak L. Bhatt: research grants from Astra Zeneca, Bristol-Myers Squibb, Eisai, Ethicon, Medtronic, Sanofi Aventis, The Medicines Company, and Amarin.
Authorship: All authors had access to the data and played a role in writing this manuscript.